MT

Maxim Tsypin

BI Biodesix: 20 patents #4 of 32Top 15%
Overall (All Time): #213,814 of 4,157,543Top 6%
20
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12230398 Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods Joanna Röder, Krista Meyer, Julia Grigorieva, Carlos Oliveira, Ami Steingrimsson +4 more 2025-02-18
10950348 Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods Joanna Röder, Krista Meyer, Julia Grigorieva, Carlos Oliveira, Arni Steingrimsson +4 more 2021-03-16
10007766 Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods Joanna Röder, Krista Meyer, Julia Grigorieva, Carlos Oliveira, Arni Steingrimsson +5 more 2018-06-26
9824182 Method and system for determining whether a drug will be effective on a patient with a disease Heinrich Röder, Julia Grigorieva 2017-11-21
9606101 Deep MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof Heinrich Röder, Senait Asmellash, Jenna Allen 2017-03-28
9279798 Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof Heinrich Röder, Senait Asmellash, Jenna Allen 2016-03-08
9152758 Method and system for determining whether a drug will be effective on a patient with a disease Heinrich Röder, Julia Grigorieva 2015-10-06
8586379 Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples Heinrich Röder, Julia Grigorieva 2013-11-19
8586380 Monitoring treatment of head and neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples Heinrich Röder, Julia Grigorieva 2013-11-19
8467988 Method and system for validation of mass spectrometer machine performance Joanna Röder, Heinrich Röder 2013-06-18
8119417 Monitoring treatment of head and neck cancer patients with drugs EGFR pathway using mass spectrometry of patient samples Heinrich Röder, Julia Grigorieva 2012-02-21
8119418 Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples Heinrich Röder, Julia Grigorieva 2012-02-21
8097469 Method and system for determining whether a drug will be effective on a patient with a disease Heinrich Röder, Julia Grigorieva 2012-01-17
8024282 Method for reliable classification of samples in clinical diagnostics using an improved method of classification Heinrich Röder 2011-09-20
7906342 Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples Heinrich Röder, Julia Grigorieva 2011-03-15
7879620 Method and system for determining whether a drug will be effective on a patient with a disease Heinrich Röder, Julia Grigorieva 2011-02-01
7867775 Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway Heinrich Röder, Julia Grigorieva 2011-01-11
7858389 Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathway Heinrich Röder, Julia Grigorieva 2010-12-28
7858390 Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway Heinrich Röder, Julia Grigorieva 2010-12-28
7736905 Method and system for determining whether a drug will be effective on a patient with a disease Heinrich Röder, Julia Grigorieva 2010-06-15